Article
Epigenetic biomarker for preeclampsia-associated preterm birth and potential preventative medicine
1 Jan 2024
Abstract excerpt
Preterm birth (PTB) has dramatically increased within the population (i.e. >10%) and preeclampsia is a significant sub-category of PTB. Currently, there are no practical clinical parameters or biomarkers which predict preeclampsia induced PTB. The current study investigates the potential use of epigenetic (DNA methylation) alterations as a maternal preeclampsia biomarker. Non-preeclampsia term births were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
